Skip to main content

Table 1 Demographics, schistosome counts and biochemical variables before treatment

From: Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen

Variable

Normal Ranges

Schistosome positive

n = 28

Schistosome negative n = 53

p value

Male%

 

78.6

81.1

 

Age (years)

 

15.0 (12.5, 21.5)

16.0 (13.0, 22.0)

0.547

Sh count (/10 mL)

 

3.0 (2.0, 11.0)

0

0.033

Albumin (g/L)

35–55

51.9 (48.5, 53.0)

55.9 (52.1, 61.5)

0.003

Globulin

20–35

36.7 (32.8, 40.1)

30.5 (22.4, 33.8)

0.005

Bilirubin (Direct) (μmol/L)

0–5

5.7 (3.4, 7.5)

5.7 (4.5, 7.1)

0.825

Bilirubin (Total) (μmol/L)

3–22

14.1 (11.4, 20.2)

14.8 (12.4, 19.2)

0.809

Creatinine (μmol/L)

50–110

99.0 (77.0, 116.0)

91.0 (75.0, 114.0)

0.587

GGT (U/L)

9–48

20.0 (16.0, 26.0)

24.0 (16.0, 33.0)

0.243

ALT (U/L)

5–35

13.0 (9.0, 16.0)

13.0 (9.0, 18.0)

0.420

AST (U/L)

7–40

33.0 (28.0, 36.0)

30.0 (25.0, 35.0)

0.825

AST/ALT ratio

0.8

2.5 (1.9, 3.1)

2.6 (2.0, 3.1)

0.457

Protein (g/L)

60–80

89.0 (82.0, 92.0)

87.0 (80.0, 91.0)

0.840

Urea (mmol/L)

2.9–8.2

2.7 (2.1, 3.1)

2.6 (2.1, 3.0)

0.344

eGFR (CKDEPI)

>  90

96.0 (80.0, 116.0)

101.0 (88.0, 127.0)

0.600

eGFR (4v-MDRD)

>  90

100.5 (82.5, 120.0)

95.0 (83.0, 123.0)

0.776

  1. Sh S. haematobium egg. eGFR (ml/min/1.73m2), proportion reported as percentage (interquartile range), biochemical variables reported as median (interquartile ranges)